<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A Rare Case of Hyper IgE Syndrome with Vocal Cords Involvement</title>
    <FirstPage>225</FirstPage>
    <LastPage>229</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Samin</FirstName>
        <LastName>Sharafian</LastName>
        <affiliation locale="en_US">Department of Allergy and Clinical Immunology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Movahedi</LastName>
        <affiliation locale="en_US">Department of Allergy and Clinical Immunology, Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Arash</FirstName>
        <LastName>Kalantari</LastName>
        <affiliation locale="en_US">Department of Allergy and Clinical Immunology, Vali-e-Asr Hospital, Imam Khomeini Hospital Complexes, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Parvaneh</LastName>
        <affiliation locale="en_US">Department of Allergy and Clinical Immunology, Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Gharagozlou</LastName>
        <affiliation locale="en_US">Department of Allergy and Clinical Immunology, Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>01</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>07</Month>
        <Day>04</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Hyperimmunoglobulin E syndrome (HIGE) is considered as a phagocytic or a newly classified complex and heterogeneous primary immunodeficiency disease with symptoms such as increased levels of immunoglobulin E, eczema, and, recurrent lung and skin infections. In this paper, we have presented a rare case of this syndrome. A 9-year-old Iranian girl presented with a history of pruritic maculopapular rash who was eventually diagnosed as a case of HIGE. In her recent admission, she had dysphonia, stridor and huge cauliflower cutaneous lesions on her neck, finger and vocal cords, which did not respond to intravenous antibiotics, and ultimately required surgical removal.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1836</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/1836/1403</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Th9 Cells as a New Player in Inflammatory Skin Disorders</title>
    <FirstPage>120</FirstPage>
    <LastPage>130</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Zohreh</FirstName>
        <LastName>Jadali</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>17</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>08</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">CD4+T cells are composed of different subpopulations that differ in developmental pathways, surface markers, and their products. Among the catalog of these cells is Th9 cell subset that has a great capacity of Interleukin (IL)-9 production. They could be involved in the pathogenic or protective immune responses. Therefore, it is important to know how Th9 cells and cytokines influence the function of the human immune system as multitasking machinery, both in isolation or after the interaction with other surrounding cells. Since an important characteristic of Th9 cells is their tropism for skin, this article reviews the physiological and pathophysiological functions of Th9 and its cytokines under normal conditions and inflammatory skin disorders.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1788</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/1788/1391</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Recent Advances in Gene Therapy and Modeling of Chronic Granulomatous Disease</title>
    <FirstPage>131</FirstPage>
    <LastPage>142</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Arefeh</FirstName>
        <LastName>Jafarian</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Gelareh</FirstName>
        <LastName>Shokri</LastName>
        <affiliation locale="en_US">Stem Cell Technology Research Center, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mahdieh</FirstName>
        <LastName>Shokrollahi Barough</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran AND Department of Cancer Immunotherapy and Regenerative Medicine, Breast Cancer Research Center, Motamed Cancer Institute, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Moin</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Pourpak</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Soleimani</LastName>
        <affiliation locale="en_US">Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>02</Month>
        <Day>12</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>07</Month>
        <Day>15</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The Chronic granulomatous disease (CGD) is a primary immunodeficiency that characterized by mutations in phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, resulting in deficient antimicrobial activity of phagocytic cells and recurrent childhood infections. Hematopoietic stem cell transplantation (HSCT) is a curative option for patients with human leukocyte antigen (HLA) matched donor, when conventional cares and therapies fail. However, in many cases when the patients have not an HLA-matched donor, they need to a method to recapitulate the function of the affected gene within the patient&#x2019;s own cells. Gene therapy is a promising approach for CGD. While, the success of retroviral or lentiviral vectors in gene therapy for CGD has been hampered by random integration and insertional activation of proto-oncogenes. These serious adverse events led to improvement and generations of viral vectors with increased safety characteristics. Gene therapy continues to progress and the advent of new technologies, such as engineered endonucleases that have shown a great promise for the treatment of genetic disease. This review focuses on the application of gene therapy for the CGD, the limitations encountered in current clinical trials, advantages and disadvantages of endonucleases in gene correction and modeling with CRISPR/Cas9 approach.&#xA0;</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1868</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/1868/1392</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Determining Laboratory Reference Values of TREC and KREC in Different Age Groups of Iranian Healthy Individuals</title>
    <FirstPage>143</FirstPage>
    <LastPage>152</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Leila</FirstName>
        <LastName>Shakerian</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Pourpak</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Somayeh</FirstName>
        <LastName>Shamlou</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Erna</FirstName>
        <LastName>Domsgen</LastName>
        <affiliation locale="en_US">ImmunoIVD, Nacka Strand, Nacka, Sweden</affiliation>
      </Author>
      <Author>
        <FirstName>Anoshirvan</FirstName>
        <LastName>Kazemnejad</LastName>
        <affiliation locale="en_US">Department of Biostatistics, Tarbiat Modares University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Dalili</LastName>
        <affiliation locale="en_US">Breastfeeding Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Nourizadeh</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>06</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Assessment of the number of T-cell receptor excision circles (TREC) and kappa-deleting recombination excision circles (KREC) copies has been recently described as biomarkers of newly formed T and B cells respectively. In this study, we aimed to explore the effects of demographic variables including age, gender, weight, height and ethnicity on these two episomal DNA molecules. Second, for the first time in our country, we determined the reference values of TREC and KREC copy numbers in different age groups of Iranian healthy individuals as a threshold for identifying T cell and B cell lymphopenia.&#xA0;The TREC and KREC copy numbers were evaluated in 251 dried blood spot (DBS) samples from healthy volunteers (age range: 0-60 years). Six primary immunodeficiency (PID) patients were included as disease controls. TREC and KREC copies were markedly reduced with increasing age. Although the levels of TREC and KREC were higher in females than males, this difference did not reach statistical significance. These findings suggest that demographic variables including age should be considered for interpretation results of the TREC/KREC assay.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1907</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/1907/1409</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">High Glucose-reduced Apoptosis in Human Breast Cancer Cells Is Mediated by Activation of NF-&#x3BA;B</title>
    <FirstPage>153</FirstPage>
    <LastPage>162</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Atefeh</FirstName>
        <LastName>Nasir Kansestani</LastName>
        <affiliation locale="en_US">Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran AND&#xA0;Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Kamran</FirstName>
        <LastName>Mansouri</LastName>
        <affiliation locale="en_US">Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Shahrooz</FirstName>
        <LastName>Hemmati</LastName>
        <affiliation locale="en_US">Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Erfan</FirstName>
        <LastName>Zare</LastName>
        <affiliation locale="en_US">Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran AND&#xA0;Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Moatafaei</LastName>
        <affiliation locale="en_US">Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>04</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>06</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Tumor cells rely on glycolysis for their energy supply with the production of lactate even in normoxia condition, which is named aerobic glycolysis or Warburg effect. Therefore, high glucose (HG) concentration provides a favorable condition for increasing proliferation, angiogenesis and decreasing apoptosis, but its molecular mechanisms are still unknown. The objective of this study is to investigate HG condition on tumor cells behavior including proliferation, apoptosis, and an angiogenesis mediator. In this study, MCF-7 derived from human breast adenocarcinoma, were cultured in DMEM with two different concentrations of glucose for 48 h (5.5 mM as normal glucose (NG) condition and 25 mM as HG condition). We used Zingiber officinale extraction for the inhibition of NF-&#x3BA;B. Cell proliferation assay was done by direct counting, cell viability by MTT method, bcl-2 by Immunocytochemistry, apoptosis by Hoechst/PI double staining and vascular endothelium growth factor (VEGF) by ELISA. Results showed that HG increased lactate production, significantly. HG increased cell proliferation, cell viability, VEGF secretion, and bcl-2 expression while it decreased apoptosis. However, when HG was combined with Zingiber officinale extraction, cell proliferation, cell viability, VEGF secretion and bcl-2 expression decreased and apoptosis increased significantly due to inhibition of NF-&#x3BA;B. Results revealed that HG increased cell proliferation, angiogenesis and decreased apoptosis due to activation of NF-&#x3BA;B pathway. Moreover, the probable mechanism of the activation of NF-&#x3BA;B in HG is increasing reactive oxygen species (ROS) in this condition that can activate NF-&#x3BA;B directly.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1761</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/1761/1406</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">T Cell Subsets Profiling in Unexplained Infertile Women with Successful and Unsuccessful in Vitro Fertilization Outcome: Focus on the Effect of Seminal Plasma</title>
    <FirstPage>163</FirstPage>
    <LastPage>172</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Kanannejad</LastName>
        <affiliation locale="en_US">Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Bahia</FirstName>
        <LastName>Namavar Jahromi</LastName>
        <affiliation locale="en_US">Department of Gynecology and Obstetrics, Shiraz University of Medical Sciences, Shiraz, Iran AND&#xA0;&#xA0;Infertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Behrouz</FirstName>
        <LastName>Gharesi-Fard</LastName>
        <affiliation locale="en_US">Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran AND Infertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>01</Month>
        <Day>06</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>03</Month>
        <Day>04</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Unexplained infertility (UI) is one of the most common diagnoses in the fertility care. Seminal plasma (SP) plays a crucial role in the regulation of female immune responses and the success of a pregnancy. In vitro&#xA0;fertilization (IVF) is a well-known method for the treatment of UI. In this study, we aimed to investigate the effect of SP on the differentiation of T helper (Th) cell subsets and the relationship between these subsets with the rate of IVF success in a group of women complicated with UI compared to those with normal pregnancy. This study was conducted on 20 UI couples (ten with successful and ten with unsuccessful IVF outcome) and 10 fertile couples as the control group. Four color flow cytometry technique was used to detect Th cell subsets in the peripheral blood mononuclear cells (PBMC) with or without stimulation by SP. Results indicated that the frequencies of IL-17+ and Foxp3+ T cells after incubation with SP was significantly increased in couples with unsuccessful IVF outcome as compared to successful and healthy groups (p&lt;0.05). Additionally, a positive correlation was observed between Th1 and Th2 cells in the unsuccessful IVF group (R=0.6, p=0.03). In summary, the results of the present study demonstrated that exposure to SP might increase Th17 and Treg cell frequencies in infertile women with unsuccessful IVF, and might also balance inflammatory to regulatory responses to finally tune-up the Th1/Th2/Th17/Treg balance and support the success of IVF.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/2262</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/2262/1414</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Downregulation of miR-542-3p Contributes to Apoptosis Resistance in Dermal Fibroblasts from Systemic Sclerosis Patients via Survivin Overexpression</title>
    <FirstPage>173</FirstPage>
    <LastPage>181</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Pegah</FirstName>
        <LastName>Vahidi Manesh</LastName>
        <affiliation locale="en_US">Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran AND Department of Cell and Molecular Biology, University of Tehran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Farazmand</LastName>
        <affiliation locale="en_US">Department of Cell and Molecular Biology, University of Tehran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farhad</FirstName>
        <LastName>Gharibdoost</LastName>
        <affiliation locale="en_US">Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Negar</FirstName>
        <LastName>Vanaki</LastName>
        <affiliation locale="en_US">Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Shayan</FirstName>
        <LastName>Mostafaei</LastName>
        <affiliation locale="en_US">Department of Community Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hoda</FirstName>
        <LastName>Kavosi</LastName>
        <affiliation locale="en_US">Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Bagher</FirstName>
        <LastName>Mahmoudi</LastName>
        <affiliation locale="en_US">Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mahdi</FirstName>
        <LastName>Mahmoudi</LastName>
        <affiliation locale="en_US">Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>06</Month>
        <Day>14</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>09</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Systemic sclerosis (SSc) is characterized by excessive production of collagens by fibroblasts that leads to vast fibrosis. Resistance to apoptosis is one of the possible underlying mechanisms of fibrosis in these patients. Survivinis involved in inhibition of apoptosis and aberrantly functions in SSc. Since dysregulation of survivin-targeting microRNAs (miRNAs) has frequently been observed in cancer and some autoimmune disorders, this study aimed to investigate their expression status in dermal fibroblasts from SSc patients. DiffuseSSc patients were selected according to American College of Rheumatology criteria. Isolated fibroblasts from 10 SSc and 10 healthy skin biopsies were cultured. After examining purity of the cells, mRNA and miRNAs extraction was performed followed by complementary DNA (cDNA) synthesis. Relative expressions ofsurvivin mRNA, miR-16-5p, miR-320a, miR-218-5p, miR-708-5p and miR-542-3p were analyzed using real time PCR. Survivin mRNA expression was significantly 1.85-fold upregulated in fibroblasts from SSc patients compared with healthy controls (p=0.046). Among the studied miRNAs, miR-542-3p expression was significantly decreased (p=0.033), while enhanced expression of miR-708-5p was observed in SSc fibroblasts (p=0.05) in comparison to healthy subjects. Downregulation of miR-542-3p significantly correlated with survivin overexpression (r=&#x2D7;0.45, p=0.049). Downregulation of miR-542-3p that is correlated with higher surviving expression levels might be a possible cause of apoptosis resistance in SSc fibroblasts, hence providing a new understanding of the disease pathogenesis.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1998</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/1998/1410</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Gelatinases Increase in Bleomycin-induced Systemic Sclerosis Mouse Model</title>
    <FirstPage>182</FirstPage>
    <LastPage>189</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Fateme</FirstName>
        <LastName>Vafashoar</LastName>
        <affiliation locale="en_US">Department of Immunology, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Kazem</FirstName>
        <LastName>Mousavizadeh</LastName>
        <affiliation locale="en_US">Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hadi</FirstName>
        <LastName>Poormoghim</LastName>
        <affiliation locale="en_US">Scleroderma Study Group, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Tavasoli</LastName>
        <affiliation locale="en_US">Department of Pathobiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Tahereh</FirstName>
        <LastName>Musavi Shabestari</LastName>
        <affiliation locale="en_US">Institute of Immunology and Infectious Diseases, Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sayed</FirstName>
        <LastName>Javadmoosavi</LastName>
        <affiliation locale="en_US">Air Pollution Research Centre, School of Public Health, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nazanin</FirstName>
        <LastName>Mojtabavi</LastName>
        <affiliation locale="en_US">Department of Immunology, Iran University of Medical Sciences, Tehran, Iran AND Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>05</Month>
        <Day>13</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>07</Month>
        <Day>08</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Systemic sclerosis is a fibrotic autoimmune disease in which aberrant remodeling of the extracellular matrix in organs disturbs their functionalities. The aim of this study was to investigate the expression of gelatinases on systemic sclerosis. Consequently, a mouse model of systemic sclerosis was employed and the gelatinolytic activity of gelatinases was evaluated on the fibrotic tissues of this model. Two groups of ten mice were considered in this work: a group of systemic sclerosis model and control group. For the generation of systemic sclerosis model, mice received bleomycin, while the control group was subjected to phosphate buffered saline (PBS) reception. Mice were tested for fibrosis by using trichrome staining, hydroxyproline measurement and &#x3B1;-SMA detection in tissue sections. Additionally, the gelatinolytic activity of matrix metalloproteinase 2 and matrix metalloproteinase 9 were measured using gelatin zymography in lungs and skin tissue homogenates. The obtained results indicated that subcutaneous injection of bleomycin-induced fibrosis in skin and lung tissues of mice. Pro and active forms of matrix methaloproteinase 9 were increased in fibrotic lung tissues (p&lt;0.05 and p&lt;0.01, respectively), while, the gelatinolytic activity of MMP2 was unaffected in these tissues. Additionally, in skin tissues of bleomycin-treated animals, both pro and active forms of MMP9 and MMP2 were increased (p&lt;0.05). Pro and active forms of gelatinases increase differently in skin and lung tissues of bleomycin-induced scleroderma.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1956</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/1956/1404</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Chitin Micro Particles Regulate Splenocytes Immune Response  in Experimental Autoimmune Encephalomyelitis</title>
    <FirstPage>190</FirstPage>
    <LastPage>199</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sanaz</FirstName>
        <LastName>Mami</LastName>
        <affiliation locale="en_US">Department of Medical Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farshid</FirstName>
        <LastName>Yeganeh</LastName>
        <affiliation locale="en_US">Department of Medical Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Elnaz</FirstName>
        <LastName>Farahani</LastName>
        <affiliation locale="en_US">Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Anissian</LastName>
        <affiliation locale="en_US">Department of Veterinary Pathology, Islamic Azad University, Abhar Branch, Abhar, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mustafa</FirstName>
        <LastName>Haji Molla Hoseini</LastName>
        <affiliation locale="en_US">Department of Medical Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>06</Month>
        <Day>12</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>11</Month>
        <Day>24</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Contrasting studies are reported on the induction of IL-10 and IFN-&#x3B3; via chitin microparticles (CMPs) during immune stimulation. Our previous studies have shown marked protection among CMP treated Leishmania-infected mice via regulated IL-10/IFN-&#x3B3; response, at the present study, once more, examined the inconsistent responses regarding the immunologic response of CMPS. To verify whether CMPs could indeed up-regulate IL-10/IFN-&#x3B3; axis, isolated spleen cells from the myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE) mice were cultured in the presence of MOG peptide and/or CMPs. The effects of CMPs on IL-10, IFN-&#x3B3; and IL-17 production were evaluated by Enzyme-linked Immunosorbent Assay (ELISA). Moreover, GATA binding protein 3 (Gata3), T-box transcription factor TBX21 (Tbx21), and RAR-related orphan receptor gamma (ROR&#x3B3;T) expressions (real-time PCR) were investigated. MOG alone stimulated the production of IFN-&#x3B3; (p&#x2264;0.004) but not, IL-10 (p&#x2264;0.140). MOG/chitin stimulation resulted in a significant increase in IFN-&#x3B3; and IL-10 levels, respectively; (p&#x2264;0.004 and p&#x2264;0.003) rather than MOG. Additionally, the expression of Tbx21 (p&#x2264;0.001), but not Gata3 (p&#x2264;0.08), was increased in the MOG/chitin-treated spleen cells. All in all, CMP supports Gata3 independent IL-10 production and promotes Tbx21 dependent IFN-&#x3B3; induction. These results, alongside our previous data, indicate that CMPs has particular adjuvant effects.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1986</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/1986/1415</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluating Serum Levels of Pentraxin-3, von Willebrand Factor and  C-X-C Motif Chemokine Ligand 13 as Inflammatory Markers of Unstable Angina Pectoris</title>
    <FirstPage>200</FirstPage>
    <LastPage>208</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Fariba</FirstName>
        <LastName>Raygan</LastName>
        <affiliation locale="en_US">Department of Cardiology, Kashan University of Medical Sciences, Kashan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hanieh</FirstName>
        <LastName>Mohammadi</LastName>
        <affiliation locale="en_US">Students&#x2019; Research Center, Kashan University of Medical Sciences, Kashan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Aniseh</FirstName>
        <LastName>Etminan</LastName>
        <affiliation locale="en_US">Students&#x2019; Research Center, Kashan University of Medical Sciences, Kashan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mojtaba</FirstName>
        <LastName>Sehat</LastName>
        <affiliation locale="en_US">Department of Community Medicine, Kashan University of Medical Sciences, Kashan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Nikoueinejad</LastName>
        <affiliation locale="en_US">Department of Immunology, Baqiyatallah University of Medical Sciences, Tehran, Iran AND&#xA0;Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>11</Month>
        <Day>07</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>01</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Unstable angina pectoris (USAP) is a complex condition in which widespread coronary inflammatory processes have important implications for clearer understanding of its pathogenesis and also its treatment. This study aimed at evaluating the diagnostic as well as prognostic value of serum inflammatory markers of pentraxin-3 (PTX-3), Von Willebrand Factor (vWf) and C-X-C Motif Chemokine Ligand 13 (CXCL13) in such patients. Out of sixty-nine patients, thirty-nine had USAP, thirty had stable angina pectoris (SAP), and thirty-nine were healthy controls. For all participants, serum PTX-3, vWf and CXCL13 levels were measured using ELISA. For each patient with USAP, the Thrombolysis in Myocardial Infarction (TIMI) and the scores of Global Registry of Acute Coronary Events (GRACE) were calculated to determine the severity of the disease. We, then, analyzed the relation of PTX-3, vWf and CXCL13 levels with TIMI and GRACE scores in patients with USAP. Serum PTX-3, vWf and CXCL13 levels were significantly higher in USAP group than those in either SAP or control groups (p&#x2C2;0.001). Strong correlation was observed between CXCL13 level and TIMI risk score (p=0.019). In receiver operating characteristic (ROC) curves, area under the curve (AUC) values of PTX3, vWf and CXCL13 for detection of USAP were 0.755, 0.751, and 0.906, respectively. The levels of serum PTX3, vWf and CXCL13 increased in patients with USAP. The notable correlation implied that CXCL13 might be a sensitive and specific biomarker for the diagnosis of USAP as well as its severity. It might also show additional diagnostic values when measured in combination with vWf.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1720</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/1720/1407</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Inhibition of Airway Contraction and Inflammation by Pomalidomide in a Male Wistar Rat Model of Ovalbumin-induced Asthma</title>
    <FirstPage>209</FirstPage>
    <LastPage>217</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Majid</FirstName>
        <LastName>Ghaderi</LastName>
        <affiliation locale="en_US">Department of Biology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Shahrbanoo</FirstName>
        <LastName>Oryan</LastName>
        <affiliation locale="en_US">Department of Biology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Namdar</FirstName>
        <LastName>Yousofvand</LastName>
        <affiliation locale="en_US">Department of Biology, Faculty of Sciences, Razi University, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Akram</FirstName>
        <LastName>Eidi</LastName>
        <affiliation locale="en_US">Department of Biology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>09</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Asthma is a chronic inflammatory disease of the airways of the lungs. Pomalidomide (POM) a therapy for multiple myeloma has been stated to have an anti-inflammatory effect. The main goal of the present study was to assess its possible effect on airway contraction and inflammation in a rat model of ovalbumin-induced asthma. Different groups of rats received saline or pomalidomide (0.4, 0.8 mg/kg) or dexamethasone (0.6 mg/kg). The asthma was induced by ovalbumin (OVA). Trachea contraction was assayed by organ bath system. Airway histology was assessed using hematoxylin and eosin method. Serum Tumor necrosis factor alpha (TNF-&#x3B1;) level was analyzed by Enzyme-Linked Immunosorbent Assay and Platelet-derived growth factor (PDGF&#x3B1;) Gene expressions were evaluated by Real-time PCR. Pomalidomide prevented ovalbumin-induced airway contraction and histopathological damage. In addition serum, TNF-&#x3B1; level was significantly (p&lt;0.05) decreased in POM treated animals compared to control (asthmatic animals that received POM vehicle). Results indicate that POM prevented the PDGF expression induced by ovalbumin. In conclusion, we found that pomalidomide ameliorated the symptoms, histopathological changes and inflammatory markers induced by ovalbumin in asthmatic rats and these effects might be related to its anti-inflammatory properties.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1805</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/1805/1417</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Is the Inflammasome Pathway Active in the Peripheral Blood of Sulfur Mustard-exposed Patients?</title>
    <FirstPage>218</FirstPage>
    <LastPage>224</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Sholeh</FirstName>
        <LastName>Etehad Asnaf</LastName>
        <affiliation locale="en_US">Department of Cell and Molecular Biology, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mitra</FirstName>
        <LastName>Sabetghadam</LastName>
        <affiliation locale="en_US">Department of Cell and Molecular Biology, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Habib</FirstName>
        <LastName>Jaafarinejad</LastName>
        <affiliation locale="en_US">Legal Medicine Research Center, Legal Medicine Organization, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Raheleh</FirstName>
        <LastName>Halabian</LastName>
        <affiliation locale="en_US">Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Shahram</FirstName>
        <LastName>Parvin</LastName>
        <affiliation locale="en_US">Chemical Injuries Research Center, Systems Biology and Poisonings Institute,  Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ensieh</FirstName>
        <LastName>Vahedi</LastName>
        <affiliation locale="en_US">Chemical Injuries Research Center, Systems Biology and Poisonings Institute,  Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nasrin</FirstName>
        <LastName>Pazoki</LastName>
        <affiliation locale="en_US">Department of Cell and Molecular Biology, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Jafar</FirstName>
        <LastName>Salimian</LastName>
        <affiliation locale="en_US">Chemical Injuries Research Center, Systems Biology and Poisonings Institute,  Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>11</Month>
        <Day>04</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>01</Month>
        <Day>06</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The mustard lung is a late consequence of exposure to sulfur mustard (SM) in veterans who had participated in the Iraq-Iran war. Three mechanisms are contributed in the pathogenesis of mustard lung including oxidative stress, protease-antiprotease imbalance, and dysregulated immune response. In the context of the immune response, the role of the inflammasome complex and their inflammatory cytokines are important. This study aims to investigate the inflammasome pathway and their inflammatory cytokine (i.e IL-1 and IL-18) in the peripheral blood of mustard lung patients as well as chronic obstructive pulmonary disease (COPD) patients. This research was conducted as a cross-sectional analytical study on 15 SM patients and was compared with 15 COPD patients and 15 healthy controls. The real-time polymerase chain reaction was used to assess gene expression levels of inflammasome components (NLRP1, NLRP3, NLRC4, and ASC), inflammatory cytokines (IL-1&#x3B2;, IL-18, and IL-1&#x3B2;R), and IL-37 as an anti-inflammatory cytokine. Finally, the data were analyzed by SPSS version 21 software. The gene expression level of molecules involved in inflammasome pathway showed a slight increase in the peripheral blood of SM and COPD patients compared to the control group. However, this difference was not statistically significant. Only IL-37 and NLRP1 had a significant increase in mustard lung and COPD patients; compared to healthy controls (p&lt;0.05). Due to the normal expression of genes involved in the inflammasome pathway, it can be stated that the inflammasome pathway is not active in the blood of mustard lung patients.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/2186</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/2186/1418</pdf_url>
  </Article>
</Articles>
